RU94017851A - Ингибиторы протеолитических ферментов на основе производных сахарина, фармацевтическая композиция для лечения дегеративных заболеваний - Google Patents
Ингибиторы протеолитических ферментов на основе производных сахарина, фармацевтическая композиция для лечения дегеративных заболеванийInfo
- Publication number
- RU94017851A RU94017851A RU94017851/04A RU94017851A RU94017851A RU 94017851 A RU94017851 A RU 94017851A RU 94017851/04 A RU94017851/04 A RU 94017851/04A RU 94017851 A RU94017851 A RU 94017851A RU 94017851 A RU94017851 A RU 94017851A
- Authority
- RU
- Russia
- Prior art keywords
- pharmaceutical composition
- diseases
- sucharine
- degerative
- inhibitors
- Prior art date
Links
- 102000035443 Peptidases Human genes 0.000 title claims 2
- 108091005771 Peptidases Proteins 0.000 title claims 2
- 229940024999 Proteolytic enzymes for treatment of wounds and ulcers Drugs 0.000 title claims 2
- 239000008194 pharmaceutical composition Substances 0.000 title claims 2
- 201000010099 disease Diseases 0.000 title 1
- 239000003112 inhibitor Substances 0.000 title 1
- 206010053643 Neurodegenerative disease Diseases 0.000 claims 1
- 150000001875 compounds Chemical class 0.000 claims 1
- 230000002255 enzymatic Effects 0.000 claims 1
Claims (1)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US066805 | 1993-05-25 | ||
US08/066,805 US5378720A (en) | 1991-12-19 | 1993-05-25 | Saccharin derivative proteolytic enzyme inhibitors |
Publications (2)
Publication Number | Publication Date |
---|---|
RU94017851A true RU94017851A (ru) | 1996-01-10 |
RU2126798C1 RU2126798C1 (ru) | 1999-02-27 |
Family
ID=22071832
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
RU94017851/04A RU2126798C1 (ru) | 1993-05-25 | 1994-05-24 | Производное сахарина или его фармацевтически приемлемая соль, фармацевтическая композиция для ингибирования протеолитических ферментов при лечении дегенеративных заболеваний |
Country Status (21)
Country | Link |
---|---|
US (2) | US5378720A (ru) |
EP (1) | EP0626378B1 (ru) |
JP (1) | JPH0770094A (ru) |
KR (1) | KR100334345B1 (ru) |
AT (1) | ATE231496T1 (ru) |
AU (1) | AU685785B2 (ru) |
CA (1) | CA2122886A1 (ru) |
CZ (1) | CZ289573B6 (ru) |
DE (1) | DE69432035D1 (ru) |
FI (1) | FI942423A (ru) |
HU (1) | HUT70760A (ru) |
IL (1) | IL109780A (ru) |
MY (1) | MY129998A (ru) |
NO (1) | NO302474B1 (ru) |
NZ (1) | NZ260585A (ru) |
PH (1) | PH31435A (ru) |
RU (1) | RU2126798C1 (ru) |
SG (1) | SG55137A1 (ru) |
SK (1) | SK281020B6 (ru) |
TW (1) | TW420679B (ru) |
UA (1) | UA44682C2 (ru) |
Families Citing this family (36)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6582728B1 (en) | 1992-07-08 | 2003-06-24 | Inhale Therapeutic Systems, Inc. | Spray drying of macromolecules to produce inhaleable dry powders |
US6509006B1 (en) | 1992-07-08 | 2003-01-21 | Inhale Therapeutic Systems, Inc. | Devices compositions and methods for the pulmonary delivery of aerosolized medicaments |
WO1995013075A1 (en) * | 1993-11-12 | 1995-05-18 | Cell Therapeutics, Inc. | Method for preventing tissue injury from hypoxia |
US6290991B1 (en) | 1994-12-02 | 2001-09-18 | Quandrant Holdings Cambridge Limited | Solid dose delivery vehicle and methods of making same |
US5556909A (en) * | 1994-12-02 | 1996-09-17 | Sanofi Winthrop Inc. | Substituted 2-arylcarbonyloxymethyl-1,2,5-thiadiazolidin-3-one 1,1-dioxide derivatives and compositions and method of use thereof |
US5541168A (en) * | 1994-12-02 | 1996-07-30 | Sterling Winthrop Inc. | Substituted 2-(phosphinyloxymethyl)-1,2,5-thiadiazolidin-3-one 1,1-dioxides and compositions and method of use thereof |
US5494925A (en) * | 1994-12-02 | 1996-02-27 | Sterling Winthrop Inc. | 2-heterocyclyloxymethyl and 2-heterocyclylthiomethyl-1,2,5-thiadiazolidin-3-one 1,1-dioxides and compositions and method of use thereof |
US5512576A (en) * | 1994-12-02 | 1996-04-30 | Sterling Winthrop Inc. | 2-substituted 1,2,5,-thiadiazolidin-3-one 1,1-dioxides and compositions and method of use thereof |
US5780014A (en) * | 1995-04-14 | 1998-07-14 | Inhale Therapeutic Systems | Method and apparatus for pulmonary administration of dry powder alpha 1-antitrypsin |
US5750550A (en) * | 1995-09-15 | 1998-05-12 | Sanofi | 2-(pyrazol-5-yl-oxymethyl)-1,2-benzisothiazol-3 (2H)-One 1, 1-dioxides and compositions and method of use thereof |
HUP9904624A2 (hu) * | 1999-12-17 | 2002-01-28 | Sanofi-Synthelabo | Szacharinszármazékok, eljárás előállításukra, az ezeket tartalmazó gyógyszerkészítmények és intermedierjeik |
AU2002351412B2 (en) * | 2001-12-21 | 2010-05-20 | Exelixis Patent Company Llc | Modulators of LXR |
US7482366B2 (en) | 2001-12-21 | 2009-01-27 | X-Ceptor Therapeutics, Inc. | Modulators of LXR |
RS52392B (en) * | 2002-02-14 | 2013-02-28 | Pharmacia Corporation | SUBSTITUTED PYRIDINONES AS P38 MAP KINASE MODULATORS |
TWI417095B (zh) | 2006-03-15 | 2013-12-01 | Janssen Pharmaceuticals Inc | 1,4-二取代之3-氰基-吡啶酮衍生物及其作為mGluR2-受體之正向異位性調節劑之用途 |
TW200900065A (en) | 2007-03-07 | 2009-01-01 | Janssen Pharmaceutica Nv | 3-cyano-4-(4-pyridinyloxy-phenyl)-pyridin-2-one derivatives |
TW200845978A (en) * | 2007-03-07 | 2008-12-01 | Janssen Pharmaceutica Nv | 3-cyano-4-(4-tetrahydropyran-phenyl)-pyridin-2-one derivatives |
ES2409215T3 (es) * | 2007-09-14 | 2013-06-25 | Janssen Pharmaceuticals, Inc. | 4-fenil-1H-piridin-2-onas 1-3-disustituidas |
SI2203439T1 (sl) | 2007-09-14 | 2011-05-31 | Ortho Mcneil Janssen Pharm | 1',3'-disubstituirani 4-fenil-3,4,5,6-tetrahidro-2H-1'H-(1,4')bipiridinil-2'-oni |
EA019085B1 (ru) | 2007-09-14 | 2014-01-30 | Янссен Фармасьютикалз, Инк. | 1',3-двузамещенные 4-(арил-х-фенил)-1н-пиридин-2-оны |
RU2492170C9 (ru) * | 2007-11-14 | 2013-12-27 | Орто-Макнейл-Янссен Фармасьютикалз, Инк. | Имидазо[1,2-а]пиридиновые производные и их применение в качестве положительных аллостерических модуляторов рецепторов mglur2 |
WO2009100250A1 (en) | 2008-02-05 | 2009-08-13 | Fibrogen, Inc. | Chromene derivatives and use thereof as hif hydroxylase activity inhibitors |
BRPI0918055A2 (pt) | 2008-09-02 | 2015-12-01 | Addex Pharmaceuticals Sa | derivados de 3-azabiciclo[3,1,0]hexila como moduladores de receptores metabotrópicos de glutamato. |
WO2010043396A1 (en) | 2008-10-16 | 2010-04-22 | Ortho-Mcneil-Janssen Pharmaceuticals, Inc. | Indole and benzomorpholine derivatives as modulators of metabotropic glutamate receptors |
CN102272117B (zh) | 2008-11-14 | 2015-06-17 | 菲布罗根有限公司 | 作为hif羟化酶抑制剂的苯并噻喃衍生物 |
CN102232074B (zh) | 2008-11-28 | 2014-12-03 | 奥梅-杨森制药有限公司 | 作为代谢性谷氨酸盐受体调节剂的吲哚和苯并噁嗪衍生物 |
ME01573B (me) | 2009-05-12 | 2014-09-20 | Addex Pharma Sa | DERIVATI 1,2,4-TRIAZOLO[4,3-a]PIRIDINA I NJIHOVA UPOTREBA U TRETMANU ILI PREVENCIJI NEUROLOŠKIH I PSIHIJATRIJSKIH POREMEĆAJA |
BRPI1010831A2 (pt) | 2009-05-12 | 2016-04-05 | Addex Pharmaceuticals Sa | derivados de 1,2,4-triazolo[4,3-a]piridina e seu como moduladores alostéricos positivos de receptores de mglur2 |
MY153913A (en) | 2009-05-12 | 2015-04-15 | Janssen Pharmaceuticals Inc | 7-aryl-1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mglur2 receptors |
US8993591B2 (en) | 2010-11-08 | 2015-03-31 | Janssen Pharmaceuticals, Inc. | 1,2,4-triazolo[4,3-a] pyridine derivatives and their use as positive allosteric modulators of MGLUR2 receptors |
JP5852664B2 (ja) | 2010-11-08 | 2016-02-03 | ジヤンセン・フアーマシユーチカルズ・インコーポレーテツド | 1,2,4−トリアゾロ[4,3−a]ピリジン誘導体およびmGluR2受容体のポジティブアロステリックモジュレーターとしてのそれらの使用 |
WO2012062751A1 (en) | 2010-11-08 | 2012-05-18 | Janssen Pharmaceuticals, Inc. | 1,2,4-TRIAZOLO[4,3-a]PYRIDINE DERIVATIVES AND THEIR USE AS POSITIVE ALLOSTERIC MODULATORS OF MGLUR2 RECEPTORS |
JO3368B1 (ar) | 2013-06-04 | 2019-03-13 | Janssen Pharmaceutica Nv | مركبات 6، 7- ثاني هيدرو بيرازولو [5،1-a] بيرازين- 4 (5 يد)- اون واستخدامها بصفة منظمات تفارغية سلبية لمستقبلات ميجلور 2 |
JO3367B1 (ar) | 2013-09-06 | 2019-03-13 | Janssen Pharmaceutica Nv | مركبات 2،1، 4- ثلاثي زولو [3،4-a] بيريدين واستخدامها بصفة منظمات تفارغية موجبة لمستقبلات ميجلور 2 |
SI3431106T1 (sl) | 2014-01-21 | 2021-03-31 | Janssen Pharmaceutica Nv | Kombinacije, ki vsebujejo pozitivne alosterične modulatorje metabotropnega glutamatergičnega receptorja podtipa 2 in njihova uporaba |
LT3096790T (lt) | 2014-01-21 | 2019-10-10 | Janssen Pharmaceutica, N.V. | Deriniai, apimantys 2 potipio metabotropinio glutamaterginio receptoriaus teigiamus alosterinius moduliatorius arba ortosterinius agonistus, ir jų panaudojimas |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2855401A (en) * | 1954-04-30 | 1958-10-07 | May & Baker Ltd | Certain n-(aminophenoxy pentyl) sulfonamide or saccharine compounds and higher homologues |
US3220940A (en) * | 1962-02-07 | 1965-11-30 | Udylite Res Corp | Electrodeposition of nickel |
US4195023A (en) * | 1975-08-20 | 1980-03-25 | Merck & Co., Inc. | 2-(2-Furoyl)1,2-benzisothiazole-3-one, 2-(2-furoyl) saccharin, and 2-(2-thenoyl) saccharin |
US4276298A (en) * | 1978-03-24 | 1981-06-30 | Merck & Co., Inc. | 2-Aryl-1,2-benzisothiazolinone-1,1-dioxides and their use as selective protease inhibitors |
DE3617976A1 (de) * | 1986-05-28 | 1988-01-14 | Alter Sa | 1,4-dihydropyridin, verfahren zu dessen herstellung und dessen verwendung in antithrombotischen medikamenten |
US5236917A (en) * | 1989-05-04 | 1993-08-17 | Sterling Winthrop Inc. | Saccharin derivatives useful as proteolytic enzyme inhibitors and compositions and method of use thereof |
WO1990013549A1 (en) * | 1989-05-04 | 1990-11-15 | Sterling Winthrop Inc. | Saccharin derivatives useful as proteolytic enzyme inhibitors and preparation thereof |
US5128339A (en) * | 1990-11-01 | 1992-07-07 | Sterling Winthrop Inc. | Proteolytic enzyme inhibition method |
AU642537B2 (en) * | 1990-11-01 | 1993-10-21 | Sanofi | 2-saccharinylmethyl aryl carboxylates useful as proteolytic enzyme inhibitors and compositions and method of use thereof |
AU656027B2 (en) * | 1991-11-15 | 1995-01-19 | Sanofi | Saccharin derivative proteolytic enzime inhibitors |
AU668694B2 (en) * | 1991-12-19 | 1996-05-16 | Sanofi-Synthelabo | Saccharin derivative proteolytic enzyme inhibitors |
-
1993
- 1993-05-25 US US08/066,805 patent/US5378720A/en not_active Expired - Fee Related
-
1994
- 1994-03-30 TW TW083102772A patent/TW420679B/zh not_active IP Right Cessation
- 1994-04-25 IL IL10978094A patent/IL109780A/en not_active IP Right Cessation
- 1994-05-04 CA CA002122886A patent/CA2122886A1/en not_active Abandoned
- 1994-05-21 DE DE69432035T patent/DE69432035D1/de not_active Expired - Lifetime
- 1994-05-21 AT AT94201437T patent/ATE231496T1/de not_active IP Right Cessation
- 1994-05-21 EP EP94201437A patent/EP0626378B1/en not_active Expired - Lifetime
- 1994-05-21 SG SG1996007480A patent/SG55137A1/en unknown
- 1994-05-24 UA UA94005229A patent/UA44682C2/uk unknown
- 1994-05-24 MY MYPI94001318A patent/MY129998A/en unknown
- 1994-05-24 NZ NZ260585A patent/NZ260585A/en unknown
- 1994-05-24 PH PH48322A patent/PH31435A/en unknown
- 1994-05-24 CZ CZ19941268A patent/CZ289573B6/cs not_active IP Right Cessation
- 1994-05-24 AU AU63280/94A patent/AU685785B2/en not_active Ceased
- 1994-05-24 JP JP6109826A patent/JPH0770094A/ja active Pending
- 1994-05-24 RU RU94017851/04A patent/RU2126798C1/ru not_active IP Right Cessation
- 1994-05-24 KR KR1019940011321A patent/KR100334345B1/ko not_active IP Right Cessation
- 1994-05-25 SK SK615-94A patent/SK281020B6/sk unknown
- 1994-05-25 FI FI942423A patent/FI942423A/fi unknown
- 1994-05-25 HU HU9401571A patent/HUT70760A/hu unknown
- 1994-05-25 NO NO941937A patent/NO302474B1/no not_active IP Right Cessation
- 1994-06-22 US US08/263,643 patent/US5466701A/en not_active Expired - Fee Related
Similar Documents
Publication | Publication Date | Title |
---|---|---|
RU94017851A (ru) | Ингибиторы протеолитических ферментов на основе производных сахарина, фармацевтическая композиция для лечения дегеративных заболеваний | |
RU92016244A (ru) | Производные сахарина-ингибиторы протеолитических ферментов | |
NO941937D0 (no) | Sakarinderivater som inhiberer proteolytiske enzymer | |
MX9207449A (es) | Inhibidores de la enzima proteolitica derivada de sacarina. | |
RU93048636A (ru) | 7-/замещенные/-8-/замещенные/-9-/замещенные амино/-6-диметил-6-дезокситетрациклины, промежуточные соединения, способы получения соединений, способ профилактики и лечения и фармацевтическая композиция | |
EA199800943A1 (ru) | Производные мочевины и их применение в качестве ингибиторов инозин-5`-монофосфат- дегидрогеназы | |
GR900100326A (en) | Saccharin derivatives useful as proteolytic enzyme inhibitors and preparation thereof | |
EP0793660A4 (en) | 2-SUBSTITUTED 1,2,5-THIADIAZOLIDIN-3-ON-1,1-DIOXIDES, COMPOSITION AND THEIR USE | |
ATE225171T1 (de) | Aminosäurederivate zur behandlung von schlaganfall | |
RU94011321A (ru) | Способ профилактики и лечения заболеваний кожи | |
PL336897A1 (en) | Novel salts of bpc peptides, pharmaceutic compositions conatining them and method of obtaining such salts | |
WO1999050671A3 (en) | Toso as a target for drug screening | |
DE68908445T2 (de) | Mittel zur Behandlung von Lebererkrankungen. | |
ES2185154T3 (es) | Metodo de uso de inhibidores de la ciclooxigenasa-2 en el tratamiento y prevencion de la demencia. | |
RU94013445A (ru) | Новое соединение, лейстродуксин н, способ его получения и терапевтическая композиция | |
RU93055681A (ru) | Ингибиторы вич-протеазы, способ их получения, их использование в фармкомпозициях | |
DE59003806D1 (de) | Zubereitung eines salzes von oxypurinol in oraler form zur behandlung von hyperuricämie. | |
RU93055683A (ru) | Ингибиторы вич-протеазы, способ их получения, их использование, композиция | |
RU93055680A (ru) | Ингибиторы вич-протеазы, способ получения, их использование, композиция | |
DE69822628D1 (de) | Zur vorbeugung oder behandlung von östrogenabhängigen krankheiten nützliche pyrrolo[2.1.5-cd]indolizin-derivate | |
IT8919204A0 (it) | Composizione per la prevenzione e la cura di parodontopatte. | |
RU93056617A (ru) | Ингибиторы ретровирусной протеазы, способ их получения, промежуточные продукты, способ лечения и фармацевтическая композиция |